Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the efficacy and safety of empagliflozin in adults with type 2 diabetes who were not adequately controlled on metformin and sitagliptin. Results indicated significant reductions in HbA1c and body weight with empagliflozin treatment.
A 12-week personalized exercise and self-management program significantly reduced systolic blood pressure in individuals with multimorbidity.
This study evaluated the impact of hypoglycemic agents combined with a high protein diet and moderate exercise on diabetes remission rates.
Cyclic yoga significantly improved metabolic health markers in women with type 2 diabetes and non-alcoholic fatty liver disease compared to a control group.
This study compared the effectiveness of glycated hemoglobin measurement and oral glucose tolerance test for screening in South Asian individuals, finding higher response and participation rates for the former.
The study evaluated the effectiveness of low-frequency self-monitoring of blood glucose in non-insulin treated type 2 diabetes patients, finding it to be sufficient and safe.
This study evaluated the impact of non-surgical periodontal therapy on glycemic control in patients with type 2 diabetes, finding significant improvements in periodontal health but no significant change in HbA1c levels.
This pilot randomized controlled trial evaluated a 12-week device-measured physical activity intervention on glycaemic control and visual functioning in individuals newly diagnosed with AGT in Ghana, finding a significant reduction in HbA1c levels.
This study evaluated the efficacy and safety of dapagliflozin combined with gliclazide in patients with Type 2 diabetes, finding significant reductions in HbA1c and fasting plasma glucose levels.
This study evaluated the efficacy of a dynamic algorithm for intravenous insulin therapy compared to a static protocol in non-critically ill patients, finding significant improvements in glycaemic control.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
